Literature DB >> 28371875

Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.

Melanie D Fox1, Li Xiao1, Miao Zhang1, Ashish M Kamat2, Arlene Siefker-Radtke3, Li Zhang4, Colin P Dinney2, Bogdan Czerniak1, Charles C Guo1.   

Abstract

OBJECTIVES: Plasmacytoid urothelial carcinoma (PUC) of the bladder is a rare histologic variant. We retrospectively analyzed a large series of bladder PUC from a single institution.
METHODS: The patients consisted of 44 men and five women with a mean age of 62 years (range, 45-86 years).
RESULTS: PUC was pure in 23 cases and mixed with other histologic types in 26 cases. All PUCs diffusely invaded the bladder wall. Most PUCs lacked immunoreactivity for the retinoblastoma (RB) gene protein (12/32) and E-cadherin (8/30). Of the 44 patients with follow-up information, 25 died of PUC at a mean of 23 months, whereas 19 patients were alive at a mean of 22 months.
CONCLUSIONS: Our findings support that bladder PUC is a highly aggressive disease. The lack of E-cadherin expression in PUCs may underlie the distinct discohesive histologic appearance, and abnormal function of the RB gene may be implicated in the development of PUC. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Bladder cancer; E-Cadherin; Immunohistochemistry; Plasmacytoid urothelial carcinoma; Retinoblastoma gene

Mesh:

Substances:

Year:  2017        PMID: 28371875     DOI: 10.1093/ajcp/aqx029

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

1.  Metastatic plasmacytoid bladder cancer causing malignant priapism.

Authors:  Ryan Pereira; Marlon Perera; Handoo Rhee
Journal:  BMJ Case Rep       Date:  2019-07-01

2.  Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.

Authors:  Michael J Hwang; Ashish M Kamat; Colin P Dinney; Bogdan Czerniak; Charles C Guo
Journal:  Am J Clin Pathol       Date:  2020-07-07       Impact factor: 2.493

3.  Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes.

Authors:  Leonidas N Diamantopoulos; Ali Raza Khaki; Petros Grivas; John L Gore; George R Schade; Andrew C Hsieh; John K Lee; Todd Yezefski; Evan Y Yu; Michael T Schweizer; Heather H Cheng; Sarah P Psutka; Daniel W Lin; Maria S Tretiakova; Funda Vakar-Lopez; Robert B Montgomery; Jonathan L Wright
Journal:  Bladder Cancer       Date:  2020-03-28

4.  [Mechanism of long-chain noncoding RNA PCGEM1 in the regulation of the invasion and metastasis of oral squamous carcinoma cells via transforming growth factor β2/Smad2 signaling pathway].

Authors:  Xu Weng; Jin-Song Li; Song Fan
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-10-01

5.  Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini-review of plasmacytoid features in the genitourinary system: A case report.

Authors:  Konstantina Zacharouli; Dimitra P Vageli; George K Koukoulis; Maria Ioannou
Journal:  Mol Clin Oncol       Date:  2022-01-20

6.  Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survival.

Authors:  Sungmin Woo; Soleen Ghafoor; Jeeban P Das; Natalie Gangai; Alvin C Goh; Herbert Alberto Vargas
Journal:  Urol Oncol       Date:  2021-11-05       Impact factor: 3.498

Review 7.  Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.

Authors:  Manju Aron
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

Review 8.  Metastatic Plasmacytoid Bladder Cancer Harboring a CDH-1 Mutation and Producing High Levels of CA 19-9. A Case Report and Literature Review.

Authors:  Mohammad Telfah; Rahul A Parikh; Da Zhang; Anup Kasi
Journal:  Am J Case Rep       Date:  2020-07-09

9.  Gastrointestinal Carcinoma with Plasmacytoid Morphology: Positivity for c-MET, Arylsulfatase, and Markers of Epithelial-Mesenchymal Transition, as Indicators of Aggressivity.

Authors:  Zsolt Kovacs; Simona Gurzu; Calin Molnar; Mihaela Sincu; Laura Banias; Catalin Satala; Ioan Jung
Journal:  J Oncol       Date:  2019-05-08       Impact factor: 4.375

10.  E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors.

Authors:  Eike Burandt; Felix Lübbersmeyer; Natalia Gorbokon; Franziska Büscheck; Andreas M Luebke; Anne Menz; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Sören Weidemann; Christoph Fraune; Katharina Möller; Frank Jacobsen; Patrick Lebok; Till Sebastian Clauditz; Guido Sauter; Ronald Simon; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Sarah Minner; Rainer Krech; David Dum; Till Krech; Andreas Holger Marx; Christian Bernreuther
Journal:  Biomark Res       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.